Found: 29
Select item for more details and to access through your institution.
Cytochrome P450 Polymorphisms and their Relationship with Premature Ovarian Failure in Premenopausal Women with Breast Cancer Receiving Doxorubicin and Cyclophosphamide.
- Published in:
- Breast Journal, 2011, v. 17, n. 5, p. 536, doi. 10.1111/j.1524-4741.2011.01144.x
- By:
- Publication type:
- Article
Cognitive Performance in Type 1 Diabetes Patients Is Associated with Cerebral White Matter Volume.
- Published in:
- Diabetes, 2007, v. 56, p. A1
- By:
- Publication type:
- Article
Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Microvascular Disease in Type 1 Diabetes Alters Brain Activation.
- Published in:
- Diabetes, 2006, v. 55, n. 2, p. 334, doi. 10.2337/diabetes.55.02.06.db05-0680
- By:
- Publication type:
- Article
Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12312
- By:
- Publication type:
- Article
Building clinically relevant outcomes across the Alzheimer’s disease spectrum.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12181
- By:
- Publication type:
- Article
Lanabecestat: Neuroimaging results in early symptomatic Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12123
- By:
- Publication type:
- Article
Reasons for study exclusion by sex in lanabecestat studies AMARANTH and DAYBREAK‐ALZ: Human/Human trials: Other.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038663
- By:
- Publication type:
- Article
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1483, doi. 10.1002/alz.12164
- By:
- Publication type:
- Article
Clinical meaningfulness addressed at Alzheimer's Association Research Roundtable.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 5, p. 814, doi. 10.1002/alz.12111
- By:
- Publication type:
- Article
FTS3‐01‐03: PERFORMANCE ON EXPLORATORY EFFICACY VARIABLES IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P873, doi. 10.1016/j.jalz.2019.06.4620
- By:
- Publication type:
- Article
FTS3‐01‐02: SUBGROUP POPULATIONS IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P872, doi. 10.1016/j.jalz.2019.06.4619
- By:
- Publication type:
- Article
DT‐01‐04: LANABECESTAT: BASELINE CHARACTERISTICS OF PARTICIPANTS RANDOMIZED IN THE PHASE 2/3 AMARANTH STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1666, doi. 10.1016/j.jalz.2018.07.006
- By:
- Publication type:
- Article
P4‐341: THE COMPUTERIZED COGNITIVE COMPOSITE (C3) AND AMYLOID STATUS AMONG NORMAL OLDER ADULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1597, doi. 10.1016/j.jalz.2018.07.164
- By:
- Publication type:
- Article
P4‐210: LANABECESTAT: SCREENING PERFORMANCE FROM THE AMARANTH STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1521, doi. 10.1016/j.jalz.2018.07.031
- By:
- Publication type:
- Article
THE INTEGRATED ALZHEIMER’S DISEASE RATING SCALE (IADRS): FINDINGS FROM THE EXPEDITION3 TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1521, doi. 10.1016/j.jalz.2017.07.649
- By:
- Publication type:
- Article
Diabetes and cognitive decline in elderly African Americans: A 15-year follow-up study
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2011, v. 7, n. 4, p. 418, doi. 10.1016/j.jalz.2010.07.003
- By:
- Publication type:
- Article
P2-077: Comparison of manual and automated determination of hippocampal volumes in MCI and older adults with cognitive complaints
- Published in:
- 2008
- By:
- Publication type:
- Abstract
IC-P1-054: Comparison of manual and automated determination of hippocampal volumes in MCI and older adults with cognitive complaints
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 2, p. 199, doi. 10.1001/jamaneurol.2019.3988
- By:
- Publication type:
- Article
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 6, p. 512, doi. 10.1001/jama.2023.13239
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling of Ziprasidone in Patients With Schizophrenia From the CATIE Study.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy.
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1475-2840-13-58
- By:
- Publication type:
- Article
How donanemab data address the coverage with evidence development questions.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 3127, doi. 10.1002/alz.13700
- By:
- Publication type:
- Article
Donanemab in Early Symptomatic Alzheimer's Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082733
- By:
- Publication type:
- Article
Incremental declines in independence associated with disease progression in early symptomatic Alzheimer's disease (AD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082395
- By:
- Publication type:
- Article
Demonstration of the iADRS as an integrated measure of global disease severity in early symptomatic Alzheimer's disease using Rasch measurement theory (RMT).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082362
- By:
- Publication type:
- Article
Distinct associations between tau PET and cognitive impairment across brain regions and cognitive domains in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078345
- By:
- Publication type:
- Article
Disease progression model using the integrated Alzheimer's Disease Rating Scale.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2253, doi. 10.1002/alz.12876
- By:
- Publication type:
- Article